Diagnosis and therapy for primary hepatic carcinoma: Transcatheter inferior phrenic arteriography and chemoembolization
Journal of Tongji Medical University · 1993
DOI: 10.1007/bf02886514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Tongji Medical University, 1993. Verfasst von H B Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Xiehe Hospital, Tongji Medical University, Wuhan. Hauptthemen laut MEDLINE: Chemoembolization, Therapeutic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Transcatheter inferior phrenic arterial (IPA) and hepatic arteriography was performed on 38 patients with advanced primary hepatic carcinoma (PHC) with blood supplied by IPA and hepatic artery. 18 patients received single treatment with hepatic arterial infusion (HAI) or embolization (HAE) 20 received double treatment with IPA and hepatic arterial infusion or embolization. The results show that the double treatment is superior to the single one. The angiographic features and mechanism of parasitization of inferior phrenic arterial supply to PHC were also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Xiehe Hospital, Tongji Medical University, Wuhan.
Zitieren
APA
Xu, H. B., & Yan, X. Q. (1993). Diagnosis and therapy for primary hepatic carcinoma: Transcatheter inferior phrenic arteriography and chemoembolization. Journal of Tongji Medical University. https://doi.org/10.1007/bf02886514
Vancouver
Xu HB, Yan XQ. Diagnosis and therapy for primary hepatic carcinoma: Transcatheter inferior phrenic arteriography and chemoembolization. Journal of Tongji Medical University. 1993. doi:10.1007/bf02886514
BibTeX
@article{Xu1993,
author = {Xu, H B and Yan, X Q},
title = {Diagnosis and therapy for primary hepatic carcinoma: Transcatheter inferior phrenic arteriography and chemoembolization},
journal = {Journal of Tongji Medical University},
year = {1993},
doi = {10.1007/bf02886514}
}
EUVIMED